APIs

Resilient supply chain requires geographic diversity

Manufacturing location is vital to securing the biopharma supply chain – for the finished product, APIs and the raw materials. How vulnerable are we?   “There’s a difference in knowing something and realizing something. We’ve known for quite a while now that we’re too dependent on other countries for our medical supplies. But during this […]

Why is life sciences data integration so hard?

A new analysis and guide from the Life Sciences data integration team at Clarivate Analytics asks the question, “Why is data integration so hard?” The paper looks at the many reasons biopharma companies might want to integrate their vast and often mixed storehouses of data – revisiting an old drug program in light of new […]

Partnering to innovate creates ‘window of opportunity’ in biopharma sourcing and procurement

Partnership strategies are essential in driving value and performance in sourcing, procurement and supply management. Executives from Johnson & Johnson, Bristol-Myers Squibb and McKinsey & Company shared their experiences during the “Innovation in Sourcing and Procurement” educational session at DCAT Week ’18 in New York in March. Supplier collaboration is the next horizon with potential […]

Changing product mix, shifting geography drive sourcing and manufacturing outlook

Manufacturing (supply) and sourcing (demand) are very much intertwined. In an industry where scaling up manufacturing or getting approvals to use a new supplier can take several months, if not years, it is critical to anticipate future needs. It is clear that one area to watch in biopharma sourcing and manufacturing is the changing product […]

For the tradition-bound biopharma industry, resisting change is no longer an option

“For nearly half a century the pharmaceutical industry has lagged other industries in terms of productivity, efficiency and, some might argue, innovation,” wrote Bikash Chatterjee. “The excuse was that, as a regulated industry, any flexibility to implement improvements is limited, and compliance is of paramount importance.” Chatterjee, president and CSO of Pharmatech Associates, made these […]